Androgens and erythropoiesis.
D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D000741:Anemia, Aplastic / Q000188:drug therapy; D000743:Anemia, Hemolytic / Q000188:drug therapy; D000818:Animals; D001711:Biotransformation; D004163:Diphosphoglyceric Acids / Q000097:blood; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D055728:Primary Myelofibrosis / Q000188:drug therapy; D051381:Rats; D013268:Stimulation, Chemical; D013739:Testosterone / Q000378:metabolism / Q000627:therapeutic use
D045930:Anabolic Agents; D000728:Androgens; D004163:Diphosphoglyceric Acids; D013739:Testosterone